OpenVSafe by OpenVAERS
Search V-safe

3KM-24850-58932

2 vaccinations 6 coded responses 13 check-ins 6 free-text entries 5 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
967 / HI
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-21
    Registered in v-safe
  3. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Eye discharge, Eye pruritus, Eye swelling — Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: Itching and swollen eyes, mucous in eyes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Arthralgia, Dyspnoea, Neck pain, Vision blurred — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Difficulty focusing, shortness of breath, extreme neck and shoulder pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  7. 2020-12-26
    Health check-in — day 7, dose 1
    Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  8. 2020-12-26
    Report sent to call center — day 7, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-01-11
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-16
    Survey response — day 28, dose 1
    MedDRA: Fatigue, Pain, Parosmia, Respiratory tract congestion, Taste disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Body aches, congestion, fatigue, altered sense of smell and taste
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-16
    Report sent to call center — day 28, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-20
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-31
    Survey response — day 7, dose 2
    MedDRA: Respiratory tract congestion — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-03
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  16. 2021-02-10
    Survey response — day 21, dose 2
    MedDRA: Abdominal pain upper, Amnesia, Diarrhoea, Dysgeusia, Fatigue, Pain, Pain in extremity, Parosmia, Taste disorder — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Diarrhea, stomach cramps, body aches, leg pain, fatigue, short term memory loss, metallic taste, altered sense of taste and smell
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  18. 2021-02-25
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-21
    Survey response — 6 months, dose 2
    MedDRA: Abnormal weight gain, Ageusia, Anosmia, Breast swelling, Fatigue, Memory impairment, Nasal discomfort, Pain, Post-acute COVID-19 syndrome, Vision blurred — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Body aches, loss of sense of smell and taste, burning sensation in nostrils, fatigue, memory problems, breast swelling, abnormal weight gain, and trouble focusing eyes. Blurred vision. I was diagnosed with COVID-19 in Oct. long hauler symptoms since.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-07-21
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  22. 2021-07-22

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech
22021-01-20Pfizer-BioNTech

Call center

5 call center cases

1 unsuccessful · 4 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-21

Systemic reaction (other): Itching and swollen eyes, mucous in eyes

2020-12-23

Systemic reaction (other): Difficulty focusing, shortness of breath, extreme neck and shoulder pain.

Release 2 — day 28, dose 1

2021-01-16

Symptoms: Body aches, congestion, fatigue, altered sense of smell and taste

Release 3 — day 7, dose 2

2021-01-31

Systemic reaction (other): Congestion

Release 4 — day 21, dose 2

2021-02-10

Symptoms: Diarrhea, stomach cramps, body aches, leg pain, fatigue, short term memory loss, metallic taste, altered sense of taste and smell

Release 9 — 6 months, dose 2

2021-07-21

Symptoms: Body aches, loss of sense of smell and taste, burning sensation in nostrils, fatigue, memory problems, breast swelling, abnormal weight gain, and trouble focusing eyes. Blurred vision. I was diagnosed with COVID-19 in Oct. long hauler symptoms since. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper ✓ ✓ ✓
SDAbnormal weight gain · · ✓
SDAgeusia · · ✓
SDAmnesia ✓ ✓ ✓
SDAnosmia · · ✓
SDBreast swelling · · ✓
SDDiarrhoea ✓ ✓ ✓
SDDysgeusia ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDMemory impairment · · ✓
SDNasal discomfort · · ✓
SDPain ✓ ✓ ✓
SDPain in extremity ✓ ✓ ✓
SDParosmia ✓ ✓ ✓
SDPost-acute COVID-19 syndrome · · ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDTaste disorder ✓ ✓ ✓
SDVision blurred · · ✓
SROArthralgia ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROEye discharge ✓ ✓ ✓
SROEye pruritus ✓ ✓ ✓
SROEye swelling ✓ ✓ ✓
SRONeck pain ✓ ✓ ✓
SROPruritus ○ ○ ○
SRORespiratory tract congestion ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release